Sponsored by: Acurian

Professor Alan Palmer FRSB PhD, MSc, BSc, Board Director of The Brain Tumour Charity
Kathryn M. Martin, M.A., Manager of Patient Recruitment Strategy, Acurian

May 2, 2017

There is scientific knowledge. And there is public perception. And often, the two collide. Nowhere is this reality more explicit than with the current state of Alzheimer’s disease research. Without a definitive cause or diagnosis – and no cure in sight – many adults see no r … Read More »

Sponsored by: Cardinal Health Regulatory Sciences

Diane Beatty, PhD, Managing Director, Regulatory Affairs and Product Development, Cardinal Health Regulatory Sciences
Todd Phillips, PharmD, RAC, Principal Scientist, Regulatory Affairs and Product Development, Cardinal Health Regulatory Sciences

April 12, 2017

FDA is committed to advancing the development of therapies that treat serious conditions and rare diseases. As part of this commitment, FDA offers expedited programs for biopharmaceutical companies to reduce development and review timelines for new drugs and biologics that a … Read More »

Sponsored by: Acurian

Roger Smith, Senior Vice President & General Manager, Acurian

April 11, 2017

After decades of delayed trial timelines, slow site setup and poor patient enrollment remain the top barriers to completing clinical studies on time and on budget. However, a new trial model has surfaced that flattens these obstacles and provides sponsors with the enrollment … Read More »

Sponsored by: Cardinal Health Specialty Solutions

Cathy Patten, Director of Clinical Operations, Cardinal Health Sonexus™ Access & Patient Support
Chadi Nabhan, MD, MBA, FACP, Chief Medical Officer, Cardinal Health Specialty Solutions

March 8, 2017

While economic reforms drive sweeping changes in healthcare, the reimbursement and access landscape for specialty drugs continues to grow more challenging. For patients facing serious illnesses and their healthcare providers, navigating the prior-authorization requirements a … Read More »

Sponsored by: DocuSign

Andrea Bradbury, Co-Founder and Chief Quality Officer, Suvoda
Jennifer Royer, Director, Life Sciences Product Marketing, DocuSign

January 25, 2017

Nearly 50% of business leaders fear they will become obsolete over the next several years, and nearly 80% feel threatened by digital startups. Why? New technologies and digital strategies are challenging existing business models and forcing companies of all sizes to reimagin … Read More »

Sponsored by: RAPP

Maryann Kuzel, SVP, Head of Healthcare Strategy, North America

November 30, 2016

There’s a population tsunami approaching: the coming of age of the Gen X and Millennial generations. And it’s fueling the rise of the new Patient Economy. These generations account for about 50% of the U.S. population, and they are a powerful force for change. In the new Pat … Read More »

Sponsored by: Cello Health

Jim Hall, President, Cello Health, BioConsulting

November 17, 2016

To be successful in developing a pharmaceutical asset you have to identify the need and define the commercial value early on in the development process, as well as revisiting and refining the value as you progress through the various phases of development. This means underst … Read More »

Sponsored by: Manatt Health

Melinda Dutton, Partner, Manatt Health
Jon Glaudemans, Managing Director, Manatt Health
Sandy Robinson, Managing Director, Manatt Health

November 16, 2016

Exciting advances in science have led to developing treatment breakthroughs—such as gene scripting therapies—that could represent the first potential cures for rare diseases and other life-threatening conditions.  Gene therapies offer dramatic promise—but also come with high … Read More »

Sponsored by: InCrowd

Caleb Costa, Moderator, Senior Vice President, Client Success
Charles Lonardo, Director of Training and Compliance
Remy Morrison, Account Director for Client Services and Syndicated Data

October 19, 2016

The tracking study is a cornerstone of good market research. But what happens when you are faced with budget cuts, unforeseen market changes, or urgent data needs? Powerful, real-time tracking technologies can help fill these gaps and complement your traditional ATU when you … Read More »

Sponsored by: Worldwide Clinical Trials

Dr. Michael Murphy, M.D., Ph.D., Chief Medical and Scientific Officer
Karen Hill, VP Global Operations, Cardiovascular
Toni Bransford, Senior Medical Director, Medical & Scientific Affairs
Chris Standley, VP Trial Technologies

September 29, 2016

Cardiovascular outcome studies can be a bit like piloting the Queen Mary – multiple compartments, complex interrelated activities, difficult to launch and bring into port. To commemorate World Heart Day on September 29th, Worldwide Clinical Trial experts will highlight commo … Read More »

Sponsored by: Cardinal Health Specialty Solutions

Kristene Castle, Principal Scientist, Regulatory Affairs and Product Development, Regulatory Sciences
Kaitlyn Riffel, Scientist III, Regulatory Affairs and Product Development, Regulatory Sciences

June 23, 2016

Standard for Exchange of Nonclinical Data (SEND) is a new formatting requirement for the submission of electronic data to the FDA. This initiative is led by the Clinical Data Interchange Standards Consortium (CDISC) with the intent to integrate clinical Study Data Tabulation … Read More »

Sponsored by: DocuSign®

Michael Hovanyetz, Director, Business Technology Team, Pfizer
Shari Perlstein, Sr. Director, Enterprise Records & Information Management, Pfizer
Ellen Reilly, Vice President, Life Sciences and Healthcare, DocuSign

June 22, 2016

Your business, your patients, and your supply chain are all global and mobile – so it’s no surprise that over 80% of life science executives are investing in a globally integrated supply chain and collaborative business models. Pharmaceutical leaders are embracing fully digi … Read More »

Sponsored by: CytoVas

Todd Johnson MD, MBA, President, CytoVas
Emile R. Mohler III, MD, FACC, Co-Founder, CytoVas
Jonni Moore, PHD, Co-Founder, CytoVas
Wade Rogers, PHD, Co-Founder, CytoVas

April 21, 2015

Learn how CytoVas’s vascular health profile assay provides clinical researchers with an earlier and more accurate way to detect a compound’s effect on vascular health. Learn how the vascular health profile assay (VHP), using a single blood sample, delivers useful information … Read More »

Sponsored by: Manatt Health

Deven McGraw
Partner, Healthcare Industry
Manatt, Phelps & Phillips LLP

March 31, 2015

Learn to Create a Global Ecosystem that Protects Stakeholders while Advancing Medicine at a New Manatt Webinar, “Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk.” Sharing clinical trial data responsibly is critical to advancing medical science.  At the same … Read More »